Hou et al. showed YTHDF2 expression was decreased in hypoxia and tumor tissues, and HIF-2α antagonist (PT2385) could restore YTHDF2 expression and inhibit HCC progression 131. The gene discussed is YTHDF2; the disease is hepatocellular carcinoma.